Advisors Preferred’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-244
| Closed | -$15.3K | – | 234 |
|
|
2023
Q1 | $15.3K | Buy |
+244
| New | +$15.3K | 0.01% | 155 |
|
|
2020
Q3 | – | Sell |
-125
| Closed | -$7K | – | 157 |
|
|
2020
Q2 | $7K | Buy |
+125
| New | +$7K | ﹤0.01% | 133 |
|
|
2019
Q2 | – | Sell |
-891
| Closed | -$49K | – | 272 |
|
|
2019
Q1 | $49K | Buy |
+891
| New | +$49K | 0.02% | 152 |
|
|
2017
Q3 | – | Sell |
-331
| Closed | -$15K | – | 269 |
|
|
2017
Q2 | $15K | Buy |
+331
| New | +$15K | 0.01% | 194 |
|
|
2015
Q4 | – | Sell |
-185
| Closed | -$8K | – | 244 |
|
|
2015
Q3 | $8K | Sell |
185
-486
| -72% | -$21K | 0.01% | 153 |
|
|
2015
Q2 | $39K | Buy |
+671
| New | +$39K | 0.02% | 134 |
|
|
2014
Q4 | – | Sell |
-1,013
| Closed | -$46.8K | – | 322 |
|
|
2014
Q3 | $46.8K | Sell |
1,013
-633
| -38% | -$29.3K | 0.03% | 143 |
|
|
2014
Q2 | $71.9K | Sell |
1,646
-6,316
| -79% | -$276K | 0.04% | 134 |
|
|
2014
Q1 | $331K | Buy |
7,962
+4,161
| +109% | +$173K | 0.15% | 114 |
|
|
2013
Q4 | $140K | Buy |
+3,801
| New | +$140K | 0.08% | 110 |
|